国家中医药管理局:刘洪斌无中医医师资格

2017-06-26 MedSci 新华社

目前,国家工商总局和国家新闻出版广电总局等主管部门按照广告以及医疗养生类节目和医药广告播出管理的要求已经采取了相关措施。

3年时间冒充多个专家身份卖各类“神药”和保健品,近日刘洪斌“虚假医疗广告”事件引发媒体关注。国家中医药管理局对此表示,虚假广告“表演者”刘洪斌不具有中医医师资格,冒用“中医药专家”名义,有关部门已经按相关管理规定采取了措施,下一步将严格规范各地中医医疗广告的审批和监督。



国家中医药管理局表示,高度关注此次媒体曝光的“专家刘洪斌”事件,虚假医药广告事件中的刘洪斌不具有中医医师资格,未在中医医疗机构任职,也不是所宣称的“苗医传人”,相关中医药社会团体中也不存在广告中提到的“中华中医协会”。刘洪斌相关行为违反了《中华人民共和国广告法》《国家新闻出版广电总局关于进一步加强医疗养生类节目和医药广告播出管理的通知》等有关要求。刘洪斌目前代言的广告虽不涉及医疗活动,但其冒用“中医药专家”等名义,对中医药声誉造成了严重的负面影响。

记者采访获悉,刘洪斌2014年-2017年活跃在地方卫视的多个种类的养生节目中,先后推销苗仙咳喘方、唐通5.0、天山雪莲、药王风痛方、苗祖定喘方、苗家活骨方、老院长祛斑方、蒙药心脑方、祝眠晚餐9种药品和保健品。她还轮番扮演祖传苗医传人、北大专家、养生保健专家、御医世家传人兼风湿病专家、祖传老中医、蒙医第五代传人,期间在一档节目里还一度换名为刘洪宾。

目前,国家工商总局和国家新闻出版广电总局等主管部门按照广告以及医疗养生类节目和医药广告播出管理的要求已经采取了相关措施。国家中医药管理局将按照整治虚假违法广告部际联席会议有关分工和要求,并依据今年7月1日即将施行的中医药法的相关要求,积极配合有关部门做好相关问题的查处工作,同时积极开展中医药文化传播和知识普及活动。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771258, encodeId=22761e71258f2, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Sun Dec 17 06:20:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946439, encodeId=ab721946439b8, content=<a href='/topic/show?id=a9b03432903' target=_blank style='color:#2F92EE;'>#医师资格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34329, encryptionId=a9b03432903, topicName=医师资格)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Sun Apr 22 16:20:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408967, encodeId=67f2140896eea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603846, encodeId=99e21603846a4, content=<a href='/topic/show?id=af6b31991de' target=_blank style='color:#2F92EE;'>#刘洪斌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31991, encryptionId=af6b31991de, topicName=刘洪斌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b32e19095426, createdName=bbwuyu_009, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=215556, encodeId=a2d221555631, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jun 26 09:33:31 CST 2017, time=2017-06-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771258, encodeId=22761e71258f2, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Sun Dec 17 06:20:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946439, encodeId=ab721946439b8, content=<a href='/topic/show?id=a9b03432903' target=_blank style='color:#2F92EE;'>#医师资格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34329, encryptionId=a9b03432903, topicName=医师资格)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Sun Apr 22 16:20:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408967, encodeId=67f2140896eea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603846, encodeId=99e21603846a4, content=<a href='/topic/show?id=af6b31991de' target=_blank style='color:#2F92EE;'>#刘洪斌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31991, encryptionId=af6b31991de, topicName=刘洪斌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b32e19095426, createdName=bbwuyu_009, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=215556, encodeId=a2d221555631, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jun 26 09:33:31 CST 2017, time=2017-06-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771258, encodeId=22761e71258f2, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Sun Dec 17 06:20:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946439, encodeId=ab721946439b8, content=<a href='/topic/show?id=a9b03432903' target=_blank style='color:#2F92EE;'>#医师资格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34329, encryptionId=a9b03432903, topicName=医师资格)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Sun Apr 22 16:20:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408967, encodeId=67f2140896eea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603846, encodeId=99e21603846a4, content=<a href='/topic/show?id=af6b31991de' target=_blank style='color:#2F92EE;'>#刘洪斌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31991, encryptionId=af6b31991de, topicName=刘洪斌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b32e19095426, createdName=bbwuyu_009, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=215556, encodeId=a2d221555631, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jun 26 09:33:31 CST 2017, time=2017-06-26, status=1, ipAttribution=)]
    2017-06-28 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771258, encodeId=22761e71258f2, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Sun Dec 17 06:20:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946439, encodeId=ab721946439b8, content=<a href='/topic/show?id=a9b03432903' target=_blank style='color:#2F92EE;'>#医师资格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34329, encryptionId=a9b03432903, topicName=医师资格)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Sun Apr 22 16:20:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408967, encodeId=67f2140896eea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603846, encodeId=99e21603846a4, content=<a href='/topic/show?id=af6b31991de' target=_blank style='color:#2F92EE;'>#刘洪斌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31991, encryptionId=af6b31991de, topicName=刘洪斌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b32e19095426, createdName=bbwuyu_009, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=215556, encodeId=a2d221555631, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jun 26 09:33:31 CST 2017, time=2017-06-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771258, encodeId=22761e71258f2, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Sun Dec 17 06:20:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946439, encodeId=ab721946439b8, content=<a href='/topic/show?id=a9b03432903' target=_blank style='color:#2F92EE;'>#医师资格#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34329, encryptionId=a9b03432903, topicName=医师资格)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Sun Apr 22 16:20:00 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408967, encodeId=67f2140896eea, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603846, encodeId=99e21603846a4, content=<a href='/topic/show?id=af6b31991de' target=_blank style='color:#2F92EE;'>#刘洪斌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31991, encryptionId=af6b31991de, topicName=刘洪斌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b32e19095426, createdName=bbwuyu_009, createdTime=Wed Jun 28 00:20:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=215556, encodeId=a2d221555631, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Mon Jun 26 09:33:31 CST 2017, time=2017-06-26, status=1, ipAttribution=)]
    2017-06-26 Y—xianghai

    学习了新知识

    0

相关资讯

北京市中医局、北京市食药监局:“神药专家”刘洪斌无此人

从北京市卫计委获悉,对于媒体报道的推销神药的刘洪斌(刘洪滨),北京市中医管理局已查实,无此人。那么神医刘洪斌(刘洪滨)是否是执业药师呢?北京青年报记者联系了北京市食药监局。经查,在北京注册的执业药师系统中,没有名为刘洪斌(刘洪滨)的人。这也意味着,“神药专家”刘洪斌(刘洪滨)不在北京许可的有药师资质的药师行列内。北京市食药监局说:“有两种情况,一是刘洪斌(刘洪滨)有执业药师,但没有在北京注册,可能